Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| CGEM (Cullinan Therapeutics, Inc.) | 30.53% | 54.58% | 5.06% | -16.79% | NA | NA | NA | … | … |
Data as of 06/05/2026, Common starting date is 01/11/2021
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| CGEM (Cullinan Therapeutics, Inc.) | 01/11/2021 | 06/05/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -17.82 | 54.58 | 5.06 | -16.79 | NA | NA | NA | … | … | 30.53 | -14.86 | 17.96 | -3.41 | -31.63 | -44.89 |
| Sharpe Ratio | NA | 0.69 | 0.03 | -0.29 | NA | NA | NA | … | … | 1.33 | -0.25 | 0.16 | -0.15 | -0.47 | -0.57 |
| Standard Deviation(%) | NA | 75.38 | 67.04 | 65.78 | NA | NA | NA | … | … | 62.97 | 72.15 | 69.94 | 51.97 | 70.43 | 79.58 |
| Draw Down(%) | NA | 36.67 | 80.41 | 83.02 | NA | NA | NA | … | … | 21.84 | 54.65 | 63.30 | 41.12 | 56.36 | 71.25 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/05/2026, Common starting date is 01/11/2021
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| CGEM (Cullinan Therapeutics, Inc.) |
-25.78%
Mar 2021 – Mar 2024 |
-19.36%
Mar 2021 – Mar 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| CGEM (Cullinan Therapeutics, Inc.) |
16.94%
May 2023 – May 2026 |
-11.17%
May 2021 – May 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart